The consortium of researchers from across europe
The signals we have identified provide important clues to the biological basis of type 2 diabetes. The challenge will be to turn these genetic findings into better ways of treating and preventing the condition, said Mark McCarthy of the center for human genetics at Oxford University, who led the study.
Type 2 diabetes is caused by [...]
While mental decline may be invisible to individual
While the mental decline may be invisible to the individual, the fact that the drop-off starts accumulating in middle age puts diabetics at greater risk later on because of reduced brain reserves, Dr. David Knopman, of the Mayo Clinic in Rochester, Minnesota, told Reuters Health.
Like a bicycle tire thats been partially deflatedyoull be OK riding [...]
In a small study of 112 children with juvenile diabetes
Enteroviruses are viruses that can thrive in the gastrointestinal tract.
They are very commonsecond only to common cold viruses — and most people who are infected with an enterovirus have no obvious illness. Others have flu-like symptoms, aching muscles or a rash and some severe viruses attack the nervous system.
Toniolo stressed that the results did not [...]
Bristol-myers Gets Eu Approval For Diabetes Drug
That means Onglyza will compete with Merck & Co.s blockbuster diabetes drug Januvia both in the EU and in the United States, where the Bristol Myers drug was approved on July 31.
Onglyza is the first diabetes drug to be launched in Europe by a partnership of New York-based Bristol-Myers and British drugmaker AstraZeneca PLC to [...]
Boehringer Sees Uphill Battle With Merck, Astra In Diabetes
Boehringers trump card could be that unlike Mercks Januvia and Bristol-Myers and AstraZenecas Onglyza, doctors wont have to adjust the dose of its pill linagliptin for patients with impaired kidney function, said Klaus Dugi, Boehringers head of medical affairs. That means doctors wont have to do extra tests for patients with kidney problems, he said. [...]
Doctors Prescribe Caveat With Sanofi Insulins Ties to Cancer
A review of studies presented by half-a-dozen doctors, involving thousands of patients, wasnt able to prove the safety of Sanofi-Aventis SAs long-acting insulin Lantus, the investigators said. The problem may be that patients dont fully respond to the insulin they already have, said Edwin Gale, professor of diabetes at the University of Bristol in the [...]
Treating Mild Diabetes During Pregnancy Beneficial
In a study of 950 women, those with mild gestational diabetes who were treated had fewer overly large babies, fewer cesarean sections and fewer pregnancy complications, compared to women who didnt have their diabetes treated.
“There is every reason to fully treat women with even the mildest (gestational diabetes) based on our results,” said the studys [...]
Cancer Alert Asked as Sanofi, Novo Diabetes Drugs Put to Test
European scientists startled medical professionals and patients in June when they reported in the Diabetologia medical journal that Sanofi-Aventis SAs Lantus, the worlds biggest-selling insulin, may increase the risk of cancer. U.S. regulators delayed a decision on Novo Nordisk A/Ss liraglutide drug until the fourth quarter after cases of thyroid cancer emerged in animal tests. [...]
Astrazeneca Denied Drugs Diabetes Link Years After Alarm
Nancy White, the saleswoman, and a colleague met with an unidentified doctor in July 2006 who reported “getting a lot of flak” from patients about Seroquels diabetes links, according to a note unsealed as part of a lawsuit. AstraZeneca wrote in November 2002 to Japanese doctors that it received a dozen reports of diabetes-related cases [...]
Mercks Januvia, Paired With Insulin, Improves Sugar Control
The findings are being presented today at the meeting of the American Diabetes Association in New Orleans. Amid a rise in obesity, 23.6 million people in the U.S. have diabetes, with about 90 percent suffering from the type-2 version, for which Januvia is approved as a treatment.
[...]